| PERIOD ENDING | 28-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 541,027 | 244,052 | 60,119 | | Cost of Revenue | 326,358 | 151,709 | 36,284 | | | Gross Profit | 214,669 | 92,343 | 23,835 | | | Operating Expenses | | Research Development | 18,323 | 10,517 | 3,810 | | Selling General and Administrative | 49,697 | 31,887 | 18,309 | | Non Recurring |
-
|
-
|
-
| | Others | 3,105 | 3,018 | 15,446 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 143,544 | 46,921 | (13,730) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (527) | 5,299 | (3,981) | | Earnings Before Interest And Taxes | 143,017 | 52,220 | (17,711) | | Interest Expense | 837 | 1,651 | 2,460 | | Income Before Tax | 142,180 | 50,569 | (20,171) | | Income Tax Expense | 54,212 | 14,464 | (1,816) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 87,968 | 36,105 | (18,355) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 87,968 | 36,105 | (18,355) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $87,968 | $36,105 | ($18,355) |
|
0.50% Nasdaq 
Income Statement
